# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Bullous Pemphigoid

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-10 of 12 results.
Efficacy and Safety of Rituximab Combined With Omalizumab in Patients With Bullous Pemphigoid
Status: Not yet recruiting
Last Changed: Jan 09, 2020
First Received: Oct 16, 2019
Disease(s): Bullous Pemphigoid
Intervention(s): Rituximab combined with Omalizumab
Locations: University of California, Davis, Department of Dermatology, Sacramento, California, United States
Efficacy and Safety of Ustekinumab in Bullous Pemphigoid
Status: Not yet recruiting
Last Changed: Oct 07, 2019
First Received: Oct 07, 2019
Disease(s): Bullous Pemphigoid
Intervention(s): Ustekinumab
Locations: Damien JOLLY, Reims, France
A Study to Evaluate the Efficacy and Safety of Dupilumab in Adult Patients With Bullous Pemphigoid
Status: Not yet recruiting
Last Changed: Feb 11, 2020
First Received: Dec 20, 2019
Disease(s): Bullous Pemphigoid
Intervention(s): dupilumab, Matching Placebo, Oral corticosteroids (OCS)
Locations: Regeneron Investigational Site, Macon, Georgia, United States
Regeneron Investigational Site, Rockville, Maryland, United States
rVA576 in Adult Mild to Moderate Bullous Pemphigoid Subjects
Status: Recruiting
Last Changed: Jan 13, 2020
First Received: Jul 29, 2019
Disease(s): Bullous Pemphigoid (BP)
Intervention(s): rVA576
Locations: University of Lubeck, Lubeck, Germany
UMCG Groningen, Groningen, Hanzeplein 1, Netherlands
Dipeptidyl Peptidase-IV Inhibitors, Risk Factor for Development of Bullous Pemphigoid?
Status: Recruiting
Last Changed: Aug 17, 2018
First Received: Aug 17, 2018
Disease(s): Bullous Pemphigoid
Intervention(s): data report
Locations: Assistance Publique Des Hopitaux de Marseille, Marseille, Paca, France
Influence of Dermocorticoids on Bone Mineral Density in Patients With Bullous Pemphigoid
Status: Not yet recruiting
Last Changed: Apr 24, 2019
First Received: Apr 24, 2019
Disease(s): Osteoporosis, Bullous Pemphigoid
Intervention(s): bone densitometry, blood test, radiographs of the thoracic and lumbar spine, Clobetasol propionate
Randomized Clinical Trial Comparing the Safety and Efficacy of Rituximab Versus Oral Cyclophosphamide in Severe Forms of Mucous Membrane Pemphigoid
Status: Recruiting
Last Changed: Oct 25, 2019
First Received: Sep 27, 2017
Disease(s): Severe Forms of Mucous Membrane Pemphigoid
Intervention(s): Rituximab 1g IV, Cyclophosphamide 50Mg Oral Tablet, Placebo of Rituximab, Placebo Oral Tablet
Locations: CHU Amiens, Amiens, France
CHU Angers, Angers, France
CH Argenteuil, Argenteuil, France
CHU Bordeaux, Bordeaux, France
Brest University Hospital, Brest, France
... and 23 other locations.
Autoimmune Blistering Diseases Study
Status: Recruiting
Last Changed: Apr 11, 2019
First Received: Apr 28, 2016
Disease(s): Pemphigus Vulgaris, Pemphigus Foliaceus, Bullous Pemphigoid
Intervention(s): Questionnaires
Locations: Hospital of the University of Pennsylvania, Department of Dermatology, Philadelphia, Pennsylvania, United States
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
University of Pennsylvania, Department of Dermatology, Philadelphia, Pennsylvania, United States
Safety, Tolerability and Activity of BIVV009 in Healthy Volunteers and Patients With Complement Mediated Disorders
Status: Recruiting
Last Changed: Dec 18, 2019
First Received: Jul 20, 2015
Disease(s): Bullous Pemphigoid (BP), Cold Agglutinin Disease (CAD), Warm Autoimmune Hemolytic Anemia (WAIHA), End-stage Renal Disease (ESRD)
Intervention(s): BIV009, Placebo
Locations: Medical University of Vienna, Vienna, Austria
Clinical Trial on the Effect of Autologous Oral Mucosal Epithelial Sheet Transplantation
Status: Available
Last Changed: Apr 20, 2016
First Received: May 29, 2014
Disease(s): Limbal Stem Cell Deficiency, Stevens-johnson Syndrome, Ocular Cicatricial Pemphigoid, Chemical Burn
Intervention(s): cultivated oral mucosal epithelial sheet transplantation
Locations: Seoul National University Hospital, Seoul, Korea, Republic of
Seoul National Unversity Hospital, Seoul, Korea, Republic of